Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00750 | 34980714 | J Nutr Sci Vitaminol (Tokyo) | Fasting, Nutrition and Weight Loss: An Approach to Refine Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00751 | 34980375 | Food Res Int | Exploring the potential mechanism of Rhodomyrtus tomentosa (Ait.) Hassk fruit phenolic rich extract on ameliorating nonalcoholic fatty liver disease by integration of transcriptomics and metabolomics profiling. | 2021 | Details |
| A00752 | 34980174 | J Transl Med | Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost. | 2022 | Details |
| A00753 | 34979169 | Toxicology | Elemicin exposure induced aberrant lipid metabolism via modulation of gut microbiota in mice. | 2022 | Details |
| A00754 | 34979142 | Toxicol Appl Pharmacol | Scopoletin and umbelliferone protect hepatocytes against palmitate- and bile acid-induced cell death by reducing endoplasmic reticulum stress and oxidative stress. | 2021 | Details |
| A00756 | 34978351 | Aliment Pharmacol Ther | Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methods. | 2022 | Details |
| A00757 | 34978298 | J Vis Exp | Isolation and Characterization of Mouse Primary Liver Sinusoidal Endothelial Cells. | 2021 | Details |
| A00758 | 34978141 | Obes Rev | Human microbiome and metabolic health: An overview of systematic reviews. | 2022 | Details |
| A00759 | 34977520 | JHEP Rep | Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions. | 2021 | Details |
| A00760 | 34977519 | JHEP Rep | Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis. | 2021 | Details |
| A00761 | 34977518 | JHEP Rep | Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis. | 2021 | Details |
| A00762 | 34977507 | iScience | In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications. | 2021 | Details |
| A00763 | 34977130 | Front Nutr | Sirt1 Promotes the Restoration of Hepatic Progenitor Cell (HPC)-Mediated Liver Fatty Injury in NAFLD Through Activating the Wnt/β-Catenin Signal Pathway. | 2021 | Details |
| A00764 | 34977118 | Front Nutr | Lactational High Fat Diet in Mice Causes Insulin Resistance and NAFLD in Male Offspring Which Is Partially Rescued by Maternal Metformin Treatment. | 2021 | Details |
| A00765 | 34975333 | Int J Biol Sci | Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential. | 2022 | Details |
| A00766 | 34975241 | J Clin Exp Hepatol | Vaccination in Chronic Liver Disease: An Update. | 2021 | Details |
| A00767 | 34974285 | Nutrition | Hepatic retinaldehyde dehydrogenases are modulated by tocopherol supplementation in mice with hepatic steatosis. | 2021 | Details |
| A00768 | 34974284 | Nutrition | Serum concentration of fatty acids in children with obesity and nonalcoholic fatty liver disease. | 2021 | Details |
| A00769 | 34974159 | Mol Metab | CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing. | 2021 | Details |
| A00770 | 34974078 | Metabolism | Cytoskeleton alterations in non-alcoholic fatty liver disease. | 2021 | Details |
| A00771 | 34973842 | Transplant Proc | Bariatric Surgery and Solid-Organ Transplantation. | 2021 | Details |
| A00772 | 34973642 | Food Chem | Metabolomic profiling of M. speciosa champ at different growth stages. | 2021 | Details |
| A00773 | 34973184 | Clin Chim Acta | The ALT upper reference interval debate: Blame it on the alcohol. | 2021 | Details |
| A00774 | 34972203 | J Crohns Colitis | Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents. | 2022 | Details |
| A00775 | 34971904 | Biochem Biophys Res Commun | Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease. | 2021 | Details |
| A00776 | 34971806 | Clin Gastroenterol Hepatol | Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population. | 2021 | Details |
| A00777 | 34971370 | J Clin Endocrinol Metab | Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00778 | 34970870 | Hepatol Commun | Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLD. | 2021 | Details |
| A00779 | 34970143 | Front Pharmacol | Ilexsaponin A1 Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism in Mice. | 2021 | Details |
| A00780 | 34969770 | Anticancer Res | Development of Non-alcoholic Steatohepatitis and Nodular Regenerative Hyperplasia in C57BL/6J Mice Fed a Fructose-containing Western Diet. | 2022 | Details |
| A00781 | 34967286 | Mini Rev Med Chem | Dietary Intake of Hydrolyzable Tannins and Condensed Tannins to Regulate Lipid Metabolism. | 2021 | Details |
| A00782 | 34967199 | Asia Pac J Clin Nutr | Dietary iron and zinc intakes and nonalcoholic fatty liver disease: A meta-analysis. | 2021 | Details |
| A00783 | 34966854 | Hepatoma Res | Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes. | 2021 | Details |
| A00784 | 34966657 | J Clin Transl Hepatol | Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). | 2021 | Details |
| A00785 | 34966656 | J Clin Transl Hepatol | Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille? | 2021 | Details |
| A00787 | 34966475 | Oxid Med Cell Longev | Structural and Functional Modulation of Gut Microbiota by Jiangzhi Granules during the Amelioration of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A00788 | 34966296 | Front Psychiatry | Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A00789 | 34966292 | Front Physiol | Relationship Between Fatty Acid Binding Protein 4 and Liver Fat in Individuals at Increased Cardiometabolic Risk. | 2021 | Details |
| A00790 | 34966282 | Front Pharmacol | Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis. | 2021 | Details |
| A00791 | 34966134 | Eur J Gastroenterol Hepatol | Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver disease. | 2021 | Details |
| A00792 | 34966133 | Curr Opin Lipidol | Metabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implications. | 2022 | Details |
| A00793 | 34965565 | Probl Radiac Med Radiobiol | SUBCLINICAL INFLAMMATION IN NON/ALCOHOLIC FATTY LIVER DISEASE AT THE REMOTE PERIOD AFTER THE CHORNOBYL ACCIDENT. | 2021 | Details |
| A00794 | 34965016 | Clin Transl Med | Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease. | 2021 | Details |
| A00795 | 34964604 | Biomacromolecules | Construction of Glycogen-Based Nanoparticles Loaded with Resveratrol for the Alleviation of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A00796 | 34964438 | Elife | Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA. | 2021 | Details |
| A00797 | 34964117 | Compr Physiol | Bile Acids, Gut Microbiome and the Road to Fatty Liver Disease. | 2021 | Details |
| A00798 | 34962148 | Metab Syndr Relat Disord | PNPLA3 rs 738409 and Other Nongenetic Factors Associated with Hepatic Steatosis Estimated by Magnetic Resonance Imaging Proton Density Fat Fraction in Adult Greek Subjects with Type 2 Diabetes Mellitus. | 2021 | Details |
| A00799 | 34962146 | Metab Syndr Relat Disord | Prevalence of Hepatic Steatosis and Fibrosis in the United States. | 2021 | Details |
| A00800 | 34962132 | Rev Esp Enferm Dig | Can NAFLD overwhelm the Spanish healthcare system in the years to come? | 2022 | Details |
| A00801 | 34960036 | Nutrients | Protective Effects of Sesamol against Liver Oxidative Stress and Inflammation in High-Fat Diet-Induced Hepatic Steatosis. | 2021 | Details |
| A00802 | 34960005 | Nutrients | Effect of Nutrition Education in NAFLD Patients Undergoing Simultaneous Hyperlipidemia Pharmacotherapy: A Randomized Controlled Trial. | 2021 | Details |
| A00803 | 34959992 | Nutrients | Curcumin in Metabolic Health and Disease. | 2021 | Details |
| A00804 | 34959990 | Nutrients | Dietary Composition and Its Association with Newly Diagnosed Nonalcoholic Fatty Liver Disease and Insulin Resistance. | 2021 | Details |
| A00805 | 34959901 | Nutrients | Role and Treatment of Insulin Resistance in Patients with Chronic Kidney Disease: A Review. | 2021 | Details |
| A00806 | 34959760 | Nutrients | Blood Levels of the SMOC1 Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization Study. | 2021 | Details |
| A00807 | 34959755 | Nutrients | The Effects of Butyrate on Induced Metabolic-Associated Fatty Liver Disease in Precision-Cut Liver Slices. | 2021 | Details |
| A00808 | 34959747 | Nutrients | High-Fructose, High-Fat Diet Alters Muscle Composition and Fuel Utilization in a Juvenile Iberian Pig Model of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00809 | 34959291 | Pharmaceutics | Transcriptome-Wide Analysis of Human Liver Reveals Age-Related Differences in the Expression of Select Functional Gene Clusters and Evidence for a PPP1R10-Governed 'Aging Cascade'. | 2021 | Details |
| A00810 | 34959259 | FASEB J | High-fat diet-induced increases in glucocorticoids contribute to the development of non-alcoholic fatty liver disease in mice. | 2022 | Details |
| A00811 | 34959119 | Biomed Pharmacother | GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease. | 2021 | Details |
| A00812 | 34959080 | J Neurol Sci | Association of chronic liver disease with cognition and brain volumes in two randomized controlled trial populations. | 2021 | Details |
| A00814 | 34958922 | Clin Gastroenterol Hepatol | Prevalence of High-risk Nonalcoholic Steatohepatitis (NASH) in the United States: Results From NHANES 2017-2018. | 2021 | Details |
| A00815 | 34958817 | Metabolism | Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD. | 2021 | Details |
| A00816 | 34958747 | Clin Gastroenterol Hepatol | Food Insecurity is Associated With Mortality Among U.S. Adults With Nonalcoholic Fatty Liver Disease and Advanced Fibrosis. | 2021 | Details |
| A00817 | 34957917 | Adipocyte | Adipose tissue plays a major role in retinoic acid-mediated metabolic homoeostasis. | 2022 | Details |
| A00818 | 34957498 | Diabetes | Hepatic CPT1A Facilitates Liver-Adipose Cross-Talk via Induction of FGF21 in Mice. | 2021 | Details |
| A00819 | 34957487 | Diabetes | Active Brown Adipose Tissue is Associated With a Healthier Metabolic Phenotype in Obesity. | 2021 | Details |
| A00820 | 34957434 | Cell Genom | Machine learning enables new insights into genetic contributions to liver fat accumulation. | 2021 | Details |
| A00821 | 34957156 | Front Med (Lausanne) | Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System. | 2021 | Details |
| A00822 | 34957088 | Front Cell Dev Biol | Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer. | 2021 | Details |
| A00823 | 34956485 | Am J Transl Res | A predictive model for the diagnosis of non-alcoholic fatty liver disease based on an integrated machine learning method. | 2021 | Details |
| A00824 | 34956386 | Evid Based Complement Alternat Med | Procyanidin B2 Alleviates Palmitic Acid-Induced Injury in HepG2 Cells via Endoplasmic Reticulum Stress Pathway. | 2021 | Details |
| A00825 | 34956171 | Front Immunol | Hepatic Macrophage as a Key Player in Fatty Liver Disease. | 2021 | Details |
| A00826 | 34956080 | Front Endocrinol (Lausanne) | Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A00827 | 34955810 | Front Aging Neurosci | Liver Health and Dementia in an Italian Older Population: Findings From the Salus in Apulia Study. | 2021 | Details |
| A00829 | 34954946 | Zhonghua Wai Ke Za Zhi | [Risk factors of newly developed nonalcoholic fatty liver disease after pancreaticoduodenectomy]. | 2022 | Details |
| A00830 | 34954945 | Zhonghua Wai Ke Za Zhi | [Clinical effect of minimally invasive duodenum preserving pancreatic head resection for benign and pre-malignant lesions of pancreatic head]. | 2022 | Details |
| A00831 | 34954593 | Eur J Med Chem | Discovery of new and highly effective quadruple FFA1 and PPARα/γ/δ agonists as potential anti-fatty liver agents. | 2021 | Details |
| A00832 | 34954499 | Redox Biol | Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation. | 2021 | Details |
| A00833 | 34954342 | Biochim Biophys Acta Mol Basis Dis | Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse. | 2021 | Details |
| A00834 | 34954022 | Free Radic Biol Med | Mitochondriotropic antioxidant based on caffeic acid AntiOxCIN4 activates Nrf2-dependent antioxidant defenses and quality control mechanisms to antagonize oxidative stress-induced cell damage. | 2021 | Details |
| A00835 | 34953171 | J Magn Reson Imaging | The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis. | 2021 | Details |
| A00836 | 34953098 | Liver Int | Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: Focusing on the non-overlap groups. | 2022 | Details |
| A00837 | 34952219 | Endocr Pract | Fatty Liver Through the Ages: Nonalcoholic Steatohepatitis. | 2021 | Details |
| A00838 | 34951993 | Gastroenterology | Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development. | 2021 | Details |
| A00839 | 34951726 | Hepatology | Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease. | 2022 | Details |
| A00840 | 34951153 | Hepatol Commun | Angiotensin Converting Enzyme-2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver. | 2021 | Details |
| A00841 | 34951036 | J Med Virol | Combining the HBcrAg decline and HBV mutations predicts spontaneous HBeAg seroconversion in chronic hepatitis B patients during the immune clearance phase. | 2022 | Details |
| A00842 | 34950996 | Indian J Gastroenterol | Fetuin-A in newly detected type 2 diabetes mellitus as a marker of non-alcoholic fatty liver disease. | 2021 | Details |
| A00844 | 34950780 | JGH Open | Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study. | 2021 | Details |
| A00845 | 34950560 | Cureus | Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A00846 | 34950107 | Front Endocrinol (Lausanne) | Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00847 | 34950105 | Front Endocrinol (Lausanne) | Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities. | 2021 | Details |
| A00848 | 34950104 | Front Endocrinol (Lausanne) | Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Concurrent Type 2 Diabetes Mellitus and Non-Alcoholic Steatohepatitis: A Review of the Evidence. | 2021 | Details |
| A00849 | 34950103 | Front Endocrinol (Lausanne) | Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A00850 | 34948230 | Int J Mol Sci | It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them? | 2021 | Details |
| A00851 | 34948020 | Int J Mol Sci | The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00852 | 34946801 | Genes (Basel) | SESN3 Inhibited SMAD3 to Relieve Its Suppression for MiR-124, Thus Regulating Pre-Adipocyte Adipogenesis. | 2021 | Details |
| A00853 | 34946689 | Molecules | Mechanochemical-Assisted Extraction and Hepatoprotective Activity Research of Flavonoids from Sea Buckthorn (Hippophaë rhamnoides L.) Pomaces. | 2021 | Details |
| A00854 | 34945677 | Foods | Lactobacillus plantarum MA2 Ameliorates Methionine and Choline-Deficient Diet Induced Non-Alcoholic Fatty Liver Disease in Rats by Improving the Intestinal Microecology and Mucosal Barrier. | 2021 | Details |